BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 27, 2006
View Archived Issues
Aerosolized hydroxychloroquine studied in phase II for asthma
Read More
Bayer concludes divestment of antiinfectives research to Santo Holding
Read More
Orphan drug designation for SLIT Amikacin
Read More
American businesses of Sankyo and Daiichi to integrate
Read More
Immtech International changes name to Immtech Pharmaceuticals
Read More
Vertex and CFFT form new collaboration to develop VX-770 for cystic fibrosis
Read More
Samaritan concluding preclinical studies of SP-233 for Alzheimer's disease
Read More
Allergan completes acquisition of Inamed
Read More
Enrollment completed in phase III study of TH-9507 for HIV lipodystrophy
Read More
Phase III hepatorenal syndrome study of terlipressin completes enrollment
Read More
Schering AG supports Bayer offer
Read More
FDA Advisory Committee recommends against approval of Sparlon for ADHD
Read More
TBC-3711 on clinical hold following rat finding
Read More
Phase I/II study evaluates nimotuzumab for NSCLC
Read More
Idenix modifies phase IIb trials of valopicitabine
Read More
Phase II findings for ACP-103 for treatment-induced psychosis in Parkinson's
Read More
Orphan drug designation for Aastrom's Tissue Repair Cells in osteonecrosis
Read More
Spectrum to acquire oncology drug assets of Targent
Read More
Ranexa now available for chronic angina
Read More
Approvable letter for Thelin in PAH
Read More
In vivo efficacy of a novel CCR3 antagonist for allergic inflammatory disease
Read More
Avidex reports new immunomodulatory agents
Read More
Recent patents report new therapeutic agents for metabolic disorders
Read More
BMS-355249: novel potentiator of NT-3-mediated trk A and trk B activation
Read More
Novel LFA-1 antagonist demonstrates biological activity in vivo
Read More
Dipyridamole analogue potently inhibits ENT1
Read More
Spotlight on prostaglandin E2 EP1 receptors as mediators of neurotoxicity
Read More